Early improvement of psychotic symptoms with lithium monotherapy as a predictor of later response in mania (2012)
- Authors:
- USP affiliated authors: GATTAZ, WAGNER FARID - FM ; FORLENZA, ORESTES VICENTE - FM
- Unidade: FM
- DOI: 10.1016/j.jpsychires.2012.08.011
- Subjects: TRANSTORNO BIPOLAR; TRANSTORNOS PSICÓTICOS; LÍTIO (TERAPIA); MANIA
- Language: Inglês
- Imprenta:
- Source:
- Título: Journal of Psychiatric Research
- ISSN: 0022-3956
- Volume/Número/Paginação/Ano: v. 46, n. 12, p.1564-1568, 2012
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
SOUSA, Rafael T. de et al. Early improvement of psychotic symptoms with lithium monotherapy as a predictor of later response in mania. Journal of Psychiatric Research, v. 46, n. 12, p. 1564-1568, 2012Tradução . . Disponível em: https://doi.org/10.1016/j.jpsychires.2012.08.011. Acesso em: 22 jan. 2026. -
APA
Sousa, R. T. de, Busnello, J. V., Forlenza, O. V., Zanetti, M. V., Soeiro-de-Souza, M. G., van de Bilt, M. T., et al. (2012). Early improvement of psychotic symptoms with lithium monotherapy as a predictor of later response in mania. Journal of Psychiatric Research, 46( 12), 1564-1568. doi:10.1016/j.jpsychires.2012.08.011 -
NLM
Sousa RT de, Busnello JV, Forlenza OV, Zanetti MV, Soeiro-de-Souza MG, van de Bilt MT, Moreno RA, Zarate Jr. CA, Gattaz WF, Machado-Vieira R. Early improvement of psychotic symptoms with lithium monotherapy as a predictor of later response in mania [Internet]. Journal of Psychiatric Research. 2012 ; 46( 12): 1564-1568.[citado 2026 jan. 22 ] Available from: https://doi.org/10.1016/j.jpsychires.2012.08.011 -
Vancouver
Sousa RT de, Busnello JV, Forlenza OV, Zanetti MV, Soeiro-de-Souza MG, van de Bilt MT, Moreno RA, Zarate Jr. CA, Gattaz WF, Machado-Vieira R. Early improvement of psychotic symptoms with lithium monotherapy as a predictor of later response in mania [Internet]. Journal of Psychiatric Research. 2012 ; 46( 12): 1564-1568.[citado 2026 jan. 22 ] Available from: https://doi.org/10.1016/j.jpsychires.2012.08.011 - Increased platelet GSK3B activity in patients with mild cognitive impairment and Alzheimer's disease
- Diagnosis and biomarkers of predementia in Alzheimer’s disease
- Three plasma metabolites in elderly patients differentiate mild cognitive impairment and Alzheimer's disease: a pilot study
- Inhibition of phospholipase A2 in rat brain decreases the levels of total Tau protein
- Single-nucleotide polymorphisms of GSK3B, GAB2 and SORL1 in late-onset Alzheimer's disease: interactions with the APOE genotype
- Long-term sertraline treatment increases expression and decreases phosphorylation of glycogen synthase kinase-3B in platelets of patients with late-life major depression
- Inhibition of phospolipase A2 modulates glycogen synthase activity and tau phosphorylation in primary cultures of cortical and hippocampal neurons
- Donepezil effects on cholesterol and oxysterol plasma levels of Alzheimer's disease patients
- Lithium increases plasma brain-derived neurotrophic factor in acute bipolar mania: a preliminary 4-week study
- Reduced Cerebrospinal Fluid Levels of Brain-Derived Neurotrophic Factor Is Associated With Cognitive Impairment in Late-Life Major Depression
Informações sobre o DOI: 10.1016/j.jpsychires.2012.08.011 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
